期刊文献+

中老年2型糖尿病患者血清25-羟维生素D水平及相关因素分析 被引量:7

Serum 25-hydroxy vitamin D level and its influencing factors in middle-old aged patients with type 2 diabetes
下载PDF
导出
摘要 目的测定中老年2型糖尿病患者(type 2 diabetes,T2DM)患者血清25羟维生素D水平并分析其影响因素。方法选取中老年T2DM患者(T2DM组)548例及健康对照组(NC组)120名,测定血清25-羟维生素D、Ca、P、FINS、FPG、HbA1c、TG、TC、LDL-C、HDL-C水平。结果 T2DM组血清25-羟维生素D水平低于NC组[(36.89±16.82)vs(45.84±17.68)nmol/L,P<0.05]。T2DM组中,男性血清25-羟维生素D水平高于女性[(38.09±16.58)vs(35.63±16.26)nmol/L,P<0.05];同年龄段受试者男性血清25-羟维生素D水平普遍高于女性,除了50~59岁年龄组外,各年龄组男性女性25-羟维生素D水平差异均有统计学意义(P<0.05);男性患者中≥70岁年龄组血清25-羟维生素D水平最高,40~49岁年龄组的25-羟维生素D水平最低,各年龄段间水平差异具有统计学意义(F=17.68,P<0.01)。女性患者中≥70岁年龄组血清25-羟维生素D水平最高,40~49岁年龄组的25-羟维生素D水平最低,各年龄段间水平差异具有统计学意义(F=13.43,P<0.01);T2DM组中血清总25-羟维生素D缺乏率为58.39%,其中女性患者缺乏率为60.82%,男性患者为56.07%,女性25-羟维生素D缺乏率显著高于男性患者,差异具有统计学意义(P<0.01);T2DM患者血清25-羟维生素D水平与Ca(r=0.072)、HOMA-β(r=0.406)呈正相关(均P<0.05),与BMI(r=-0.574)、P(r=-0.098)、TC(r=-0.401)、TG(r=-0.325)、LDL-C(r=-0.457)、FPG(r=-0.238)、HbA1c(r=-0.363)、HOMA-IR(r=-0.251)呈负相关(均P<0.05)。结论中老年2型糖尿病患者血清25-羟维生素D水平低于正常人,且受年龄、性别、血糖、血脂、血清钙磷水平及胰岛功能等因素的影响。 Objective To investigate the serum 25-hydroxy vitamin D level and its influencing factors in middle-old aged patients with type 2 diabetes (T2DM). Methods Total 548 middle-old aged patients with type 2 diabetes(280 males and 268 females) and 120 healthy subjects(60 males and 60 females) were enrolled in the study. Fasting blood samples were collected and serum 25-hydroxy vitamin D, Ca, P, FINS, FPG, HbAlc, TG, TC, LDL-C, HDL-C were measured. Results Serum 25-hydroxy vitamin D in diabetic patients was (36.89 ± 16.82 ) nmol/L, and that in healthy controls was (45.84±17.68 ) nmol/L ( P 〈 0.05 ). The mean serum 25-hydroxy vitamin D level in male diabetic patients was higher than that in female patients[ (38.09 ±16.58 ) nmol/L vs(35.63± 16.26) nmol/L, P 〈 0.05 ]. Serum 25-hydroxy vitamin D level in male patients was significantly higher than female patients in all age group except 50 - 59 ( P 〈 0.05 ). In male patients, 25-hydroxy vitamin D level in age group 〉I 70 was the highest, that in age group 40 -49 was the lowest, there were significant difference among different age group ( F = 17. 68, P 〈 0. 01 ). In female patients, 25- hydroxy vitamin D level in age group ≥70 was the highest, that in age group 40 -49 was the lowest, there were significant difference among different age groups ( F = 13.43, P 〈 0.01 ). The 25-hydroxy vitamin D deficiency rate in T2DM patients was 58.39% (60.82% for female and 56.07% for male, P 〈0.01 ). 25-hydroxy vitamin D was positively correlated with Ca( r = 0. 072)and HOMA-[3 (r = 0. 406) ( both P 〈 0.05 ), and negatively correlated with BMI ( r = - 0.574 ), P ( r = - 0.098 ), TC ( r = -0.401), TG(r = -0.325), LDL-C(r = -0.457), FPG(r = -0. 238), HbAlc(r = -0. 363) and HOMA-IR(r = - 0. 251 ) ( all P 〈 0.05 ). Conclusion Serum 25-hydroxy vitamin D concentration in middle-old aged patients with type 2 diabetes is significantly lower than in healthy subjects, and influenced by age, gender, serum Ca, P, blood glucose, cholesterol and pancreas islet function.
出处 《同济大学学报(医学版)》 CAS 2017年第2期84-88,94,共6页 Journal of Tongji University(Medical Science)
基金 国家"八六三"高技术研究发展计划(2014AA022304)
关键词 2型糖尿病 中老年 25-羟维生素D 影响因素 type 2 diabetes middle-aged and elderly 25-hydroxy vitamin D influence factor
  • 相关文献

参考文献3

二级参考文献52

  • 1A. Mithal,D. A. Wahl,J.-P. Bonjour,P. Burckhardt,B. Dawson-Hughes,J. A. Eisman,G. El-Hajj Fuleihan,R. G. Josse,P. Lips,J. Morales-Torres.Global vitamin D status and determinants of hypovitaminosis D[J]. Osteoporosis International . 2009 (11)
  • 2G. Guardia,N. Parikh,T. Eskridge,E. Phillips,G. Divine,D. Sudhaker Rao.Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications[J]. Osteoporosis International . 2008 (1)
  • 3S. Boonen,H. A. Bischoff-Ferrari,C. Cooper,P. Lips,O. Ljunggren,P. J. Meunier,J.-Y. Reginster.Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence[J]. Calcified Tissue International . 2006 (5)
  • 4D. Sudhaker Rao MB, BS, FACP, FACE,Suhad Alqurashi MD.Management of vitamin D depletion in postmenopausal women[J]. Current Osteoporosis Reports . 2003 (3)
  • 5G. Isaia,R. Giorgino,G. B. Rini,M. Bevilacqua,D. Maugeri,S. Adami.Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors[J]. Osteoporosis International . 2003 (7)
  • 6R. P. Heaney.Vitamin D: How Much Do We Need, and How Much is Too Much?[J]. Osteoporosis International . 2000 (7)
  • 7S. T. Haden,G. E. H. Fuleihan,J. E. Angell,N. M. Cotran,M. S. LeBoff.Calcidiol and PTH Levels in Women Attending an Osteoporosis Program[J]. Calcified Tissue International . 1999 (4)
  • 8P. Bettica,M. Bevilacqua,T. Vago,G. Norbiato.High Prevalence of Hypovitaminosis D among Free-Living Postmenopausal Women Referred to an Osteoporosis Outpatient Clinic in Northern Italy for Initial Screening[J]. Osteoporosis International . 1999 (3)
  • 9M.-C. Chapuy,P. Preziosi,M. Maamer,S. Arnaud,P. Galan,S. Hercberg,P.J. Meunier.Prevalence of Vitamin D Insufficiency in an Adult Normal Population[J]. Osteoporosis International . 1997 (5)
  • 10Holick MF.High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings . 2006

共引文献156

同被引文献47

引证文献7

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部